These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1353110)

  • 21. The cost-benefit approach to pricing new medicines: doxazosin versus beta-blocker treatment in Sweden.
    Lindgren B
    Am Heart J; 1990 Mar; 119(3 Pt 2):748-53. PubMed ID: 1968701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience with doxazosin in general medical practice.
    Rosenthal J
    Am Heart J; 1988 Dec; 116(6 Pt 2):1748-57. PubMed ID: 2904745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein.
    Kincaid-Smith P
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():75-83. PubMed ID: 2575178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
    Nash DT; Schonfeld G; Reeves RL; Black H; Weidler DJ
    Am J Cardiol; 1987 May; 59(14):87G-90G. PubMed ID: 2884859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effects of doxazosin, an alpha 1-blocker, on serum lipids in hypertensive patients.
    Ishimitsu T; Yagi S; Sugishita Y; Fujimura A; Ebihara A; Sakamaki T; Murata K; Saito A
    Hypertens Res; 1996 Mar; 19(1):43-9. PubMed ID: 8829823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxazosin therapy in the treatment of diabetic hypertension.
    Feher MD
    Am Heart J; 1991 Apr; 121(4 Pt 2):1294-301. PubMed ID: 1826186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Within patient comparison of prazosin and UK-33,274. A new alpha-adrenoceptor-antagonist.
    de Leeuw PW; Ligthart JJ; Smout AJ; Birkenhäger WH
    Eur J Clin Pharmacol; 1982; 23(5):397-401. PubMed ID: 6129979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiency.
    Bartels AC; de Vries PM; Oe LP; van Bronswÿk H; Donker AJ; Réveillaud RJ; Fillastre JP; Zech P
    Am Heart J; 1988 Dec; 116(6 Pt 2):1772-7. PubMed ID: 2904749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxazosin in the treatment of mild and moderate essential hypertension in general medical practice.
    van den Hogen AL
    Am Heart J; 1988 Dec; 116(6 Pt 2):1757-62. PubMed ID: 2904746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension.
    Nechwatal W; Berger J; Blumrich W; Bouzo H; Brandl K; Braun S; Laukaitis A; Müller G; Ryba W; Schreiegg J
    Am Heart J; 1988 Dec; 116(6 Pt 2):1806-14. PubMed ID: 2904755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxazosin: a newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma.
    Miura Y; Yoshinaga K
    Am Heart J; 1988 Dec; 116(6 Pt 2):1785-9. PubMed ID: 2904751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy.
    Englert RG; Mauersberger H
    Am Heart J; 1988 Dec; 116(6 Pt 2):1826-32. PubMed ID: 2904758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-blocker therapy of hypertension. An unfulfilled promise.
    Khoury AF; Kaplan NM
    JAMA; 1991 Jul; 266(3):394-8. PubMed ID: 1676077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of doxazosin and enalapril in the treatment of mild and moderate essential hypertension.
    Taylor SH; Lee PS; Sharma SK
    Am Heart J; 1988 Dec; 116(6 Pt 2):1820-5. PubMed ID: 2904757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-1 blockers. A new generation of antihypertensive agents.
    Humphreys JE; Waite MA
    J Clin Pharm Ther; 1989 Aug; 14(4):263-83. PubMed ID: 2571616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxazosin in the treatment of mild or moderate essential hypertension: an echocardiographic study.
    Corral JL; López NC; Pecorelli A; Rincón LA; Terán VD
    Am Heart J; 1991 Jan; 121(1 Pt 2):352-6. PubMed ID: 1824660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
    Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive therapy in the geriatric patient: II. A review of the alpha1-adrenergic blocking agents.
    Studer JA; Piepho RW
    J Clin Pharmacol; 1993 Jan; 33(1):2-13. PubMed ID: 8094084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism.
    Pool JL
    Am Heart J; 1991 Jan; 121(1 Pt 2):251-9; discussion 259-60. PubMed ID: 1824647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of doxazosin in hypertension therapy.
    Hayduk K
    Am J Cardiol; 1987 May; 59(14):35G-39G. PubMed ID: 2884851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.